Flagship Ventures Fund V, L.P.

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Flagship Ventures Fund V, L.P. sits at the top of its group. 7 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.

Stakes it holds

Flagship Ventures Fund V, L.P. has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).

• Foghorn Therapeutics Inc.SCHEDULE 13D/A May 24, 2024 to Jan 13, 2026²
• Omega Therapeutics, Inc.SCHEDULE 13D/A Feb 27, 2023 to Dec 31, 2024³
• Sana BiotechnologySC 13G/A Feb 14, 2022 to Feb 14, 2024⁴
• Sigilon Therapeutics, Inc.SC 13G/A Feb 14, 2024⁵
• Evelo Biosciences, Inc.SC 13D/A Jun 1, 2022 to Jul 13, 2023⁶
• Codiak BioSciences, Inc.SC 13G/A Feb 14, 2023⁷